4.1 Skin Lesions: Primary, Secondary, and Vascular Lesions

The skin serves as the body's primary protective barrier against pathogens, physical trauma, and chemical injury. Throughout life, internal biological changes and environmental insults produce visible cutaneous variations known as skin lesions. In professional esthetics, understanding lesion morphology is essential for client safety. Licensed estheticians must recognize the difference between benign conditions treatable in the salon and pathological disorders requiring immediate physician referral.

Primary Skin Lesions

Primary lesions are physical changes in skin structure resulting directly from disease, trauma, or cellular alteration. They represent the initial presentation of a disorder before modification by scratching, infection, or healing.

Clinical Evaluation of Primary Lesions

Identifying primary lesions requires visual inspection under magnification and gentle palpation:

• A macule exhibits only color variation without elevation or depression; running a gloved finger across it reveals no tactile textural change. When a flat macule exceeds 1 cm, it is classified as a patch.
• A papule is a distinct solid bump elevated above the epidermal plane containing no fluid. When papules coalesce into a broad lesion exceeding 1 cm, it forms a plaque.
• Fluid-filled lesions require differentiating serous fluid from purulent exudate. A vesicle is a small blister under 1 cm holding clear serous fluid (classic in herpes simplex; an absolute service contraindication). A bulla is a larger blister exceeding 1 cm typically caused by burn or shear trauma. In contrast, a pustule contains white or yellowish pus consisting of neutrophils and cellular debris, indicating active inflammation.
• Nodules and cysts involve deeper structures. A nodule is a solid, firm dermal mass. A cyst is an enclosed sac lined with true epithelium containing fluid or semi-solid matter. Estheticians must never attempt manual extraction on cysts; doing so causes deep dermal rupture, vascular hemorrhage, and permanent scarring.

---

Secondary Skin Lesions

Secondary lesions develop in later stages of disease progression or stem from external manipulation, scratching, or tissue repair.

• Crust: Dried exudate, blood, pus, or sebum that hardens on the skin surface during healing (e.g., scabs on ruptured pustules or impetigo). Estheticians must never pick or remove crusts, as premature removal exposes raw tissue to bacterial infection and promotes scarring.
• Scale: Excessive shedding or accumulation of dead, horny epidermal corneocytes (e.g., psoriasis, seborrheic dermatitis, xerosis).
• Fissure: A linear crack or split penetrating through the epidermis into the vascularized dermis. Fissures occur where skin loses elasticity under tension and severe dehydration, such as chapped lips, fingertips, or cracked heels.
• Erosion: A shallow, moist loss of superficial epidermis that does not penetrate past the basement membrane. Seen after vesicles unroof, erosions heal without scarring because the dermis remains undamaged.
• Ulcer: A deep, open crater extending through the epidermis into the dermis or subcutaneous layer, accompanied by tissue necrosis and discharge. Ulcers heal with scar tissue and represent an absolute service contraindication.
• Excoriation: A hollowed-out scratch or abrasion caused by mechanical trauma (e.g., scratches, neurotic excoriation, or picking at acne blemishes).
• Cicatrix (Scar): Dense collagenous connective tissue that replaces normal dermal architecture after a full-thickness cutaneous wound. Normal skin appendages (hair follicles and glands) do not regenerate within scar tissue.
• Keloid: An abnormal, thick proliferation of fibrous collagen extending beyond original wound boundaries. Keloids are firm, rubbery, recur frequently after excision, and show higher incidence in Fitzpatrick skin phototypes IV–VI. Aggressive modalities causing micro-trauma must be avoided in clients prone to keloids.

---

Vascular Lesions and Rosacea

Vascular lesions involve abnormal dilation, proliferation, or structural damage to cutaneous microvessels.

Telangiectasia and Angiomas

• Telangiectasia (Couperose Skin): Permanently dilated superficial capillaries and venules visible as thin, branching red threads across the nose, cheeks, and chin. Caused by photoaging, genetic weakness, thermal trauma, or aggressive extraction pressure.
• Cherry Angioma: A benign, small, bright red papule composed of clustered, dilated capillary loops, common on the trunk of mature adults.
• Spider Angioma: A central dilated arteriole with radiating spider-like capillary legs, often associated with elevated estrogen levels or sun exposure.

Rosacea Subtypes and Triggers

Rosacea is a chronic inflammatory disorder of the central face driven by neurovascular instability, innate immune activation, and vascular hyper-reactivity. Its four clinical subtypes are:

1. Erythematotelangiectatic Rosacea: Persistent central facial erythema, flushing, visible telangiectasia, and stinging sensitivity with a compromised barrier.
2. Papulopustular Rosacea: Central facial redness accompanied by inflammatory papules and pustules; distinguished from acne by the absence of comedones.
3. Phymatous Rosacea: Skin thickening and irregular surface contours, most frequently manifesting as rhinophyma (a bulbous, lobulated nose with enlarged follicular pores).
4. Ocular Rosacea: Chronic eyelid inflammation (blepharitis), conjunctival hyperemia, dryness, burning, and light sensitivity.

Common triggers include thermal heat, hot facial steam, alcoholic beverages, spicy foods (capsaicin), ultraviolet radiation, extreme cold or wind, and strenuous exercise. Treatment protocols must eliminate direct steam and coarse scrubs, utilizing cool compresses, soothing botanicals (bisabolol, chamomile), and barrier-supportive lipids.

---

Clinical Scope and Referral Guidelines

Estheticians observe, analyze, and describe skin conditions to tailor safe, non-invasive cosmetic treatments, but are legally prohibited from diagnosing medical conditions or prescribing pharmaceutical therapies.